Scancell Holdings PLC
LSE:SCLP
Scancell Holdings PLC
LSE:SCLP
Price:
9.1 GBX
-1.62%
Market Closed
Updated:
May 3, 2024
Scancell Holdings PLC
Cash from Operating Activities
|
Scancell Holdings PLC
Cash from Operating Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Scancell Holdings PLC
LSE:SCLP
|
Cash from Operating Activities
-£10.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Operating Activities
-$160.3m
|
CAGR 3-Years
-147%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Operating Activities
-$145.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Operating Activities
-$60.6m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Operating Activities
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Operating Activities
£44.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
See Also
What is Scancell Holdings PLC's Cash from Operating Activities?
Cash from Operating Activities
-10.5m
GBP
-10.5m
GBP
Based on the financial report for Oct 31, 2023, Scancell Holdings PLC's Cash from Operating Activities amounts to -10.5m GBP.
What is Scancell Holdings PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-17%
-17%
Over the last year, the Cash from Operating Activities growth was -6%. The average annual Cash from Operating Activities growth rates for Scancell Holdings PLC have been -24% over the past three years , -13% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
